Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency.
Li Z, Lai X, Fu S, Ren L, Cai H, Zhang H, Gu Z, Ma X, Luo K. · 2022
Read Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency. by Li Z, Lai X, Fu S, Ren L, Cai H, Zhang H, Gu Z, Ma X, Luo K. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9353475.txt.
Description
Li and co-authors review how making cancer cells die in an immunogenic way can boost immunotherapy. Such death spills danger signals and tumor antigens into the surroundings. Dendritic cells mature on the signal and killer T cells move in. The shift can thaw a cold, suppressive tumor setting.
The review centers on nano-sized delivery systems that trigger this death on target. They can carry chemo drugs, light-activated agents, heat agents, or radiation sensitizers. Timed release at the tumor raises effect and cuts side harm. Immune drugs can ride along for a combined strike. Only 10 to 30% of patients gain from checkpoint drugs today. The authors argue that forced immunogenic death can lift that share. Design rules for the carriers close the survey.
Catalog record
| CREATOR | Li Z, Lai X, Fu S, Ren L, Cai H, Zhang H, Gu Z, Ma X, Luo K. |
|---|---|
| YEAR | 2022 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 134 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |